Soiron Rolf
     

Albert M. Baehny, a Swiss citizen, holds a degree in biology from the University of Fribourg, Switzerland.   

 

  • Chairperson of the Board of Directors of Lonza Group Ltd (since 2018)
  • Member of the Board of Directors (since April 2017)

 

Current activities and functions:

  • Member of the Board of Investis Group Holding SA (since June 2016)
  • Chairman of the Board of Directors of Geberit (since 2011)

 

Former activities and functions:

  • CEO of Geberit Group (2005-2014)
  • Head of Group Division Marketing and Sales Europe for Geberit Group (2003-2004)
  • Senior Vice President at Wacker Chemie AG (2001-2002)

Various marketing, sales, strategic planning and global management positions with:

  • Vantico (2000-2001)
  • Ciba-Geigy / Ciba Specialty Chemicals (1994-2000)
  • Dow Chemicals Europe (1981-1993)
  • Serono-Hypolab (1979-1981)
     
 Aebischer Patrick  

Patrick Aebischer holds a doctorate in medicine from the University of Geneva. He has received numerous honors, including the Robert Bing Prize of the Swiss Academy of Medicine and the Pfizer Foundation Prize for Clinical Neurosciences.

  • Member of the Board of Directors (since March 2008), Vice Chairperson

 

Current activities and functions: 

  • Senior Partner of NanoDimension Management Limited (since 2017)
  • Member of the Board of Directors of Logitech SA (since 2016)
  • Member of the Board of Directors of Nestlé SA (since 2015)
  • Scientific technical committee member of the Italian Institute of Technology (since 2015)
  • Chairman of the Advisory Board of the Novartis Venture Fund (since 2014)
  • Member of the Singapore Biomedical Sciences International Advisory Council (since 2013)
  • Chairman of the Board of Amazentis SA (since 2007)
  • Professor of Neurosciences, Swiss Federal Institute of Technology Lausanne (EPFL) (since 2000)

Former activities and functions:

  • President of the Swiss Federal Institute of Technology of Lausanne (EPFL) (2000–2016)
  • Member of the Foundation Board of the World Economic Forum (2013–2016)

 
     
Bauer Werner
  

Werner Bauer holds a diploma and PhD in Chemical Engineering from the University ErlangenNürnberg. He has received several scientific honors, among others the BioAlps Award 2011 and Honorary Senator from the Technical University of Munich.

  • Member of the Board of Directors of Lonza Group Ltd (since April 2013)

 

Current activities and functions: 

  • Vice-Chairman  of the Board of Directors of Givaudan SA (since 2014)
  • Vice-Chairman of the Supervisory Board of Bertelsmann SE & Co. KGaA (since 2012) and Chairman of the Board of Trustees of the Bertelsmann Foundation (since 2011)
  • Member of the Supervisory Board of GEAGroup AG (since 2011)

Former activities and functions:

  • Chairman of the Supervisory Board of Nestlé Deutschland AG (2007–2017)
  • Executive Vice President of Nestlé S.A., Head of Innovation, Technology, Research and Development (2007–2013)
  • Executive Vice President of Nestlé S.A., Head of Technical, Production, Environment, Research & Development (2002–2007)
  • Various managerial positions of increasing responsibility at Nestlé (1990–2002)
  • Chairman of the Board of Directors of Galderma Pharma SA (2011–2014)
  • Member of the Board of Directors of L’OREAL, France (2005–2012)
  • Member of the Board of Directors of Alcon Inc., Switzerland (2002–2010)
  • Director of the Fraunhofer Institute for Food Technology & Packaging (1985–1990)
  • Professor of Chemical Engineering at the Technical University of Hamburg (1980–1985)
               
     
Angelica Kohlmann
  

Angelica Kohlmann, a German-Brazilian citizen, holds an MD and doctorate in medicine from Hamburg University.

 

  • Member of the Board of Directors of Lonza Group Ltd (since May 2018)

 

Current activities and functions: 

  • Member International Advisory Board IE University and BusinessSchool, Madrid (since 2017)                
  • Chairman Board of Directors, Flowerkid AG (Diagnostics and CancerTherapeutics, since 2014)
  • Chairman Board of Directors Kohlmann & Co AG (since 2013)
  • International investor in biotech and tech, based in Switzerland(since 2014)
  • Board Observer Teralytics AG (since 2017)
  • Chairman Advisory Board Peter Drucker Society Europe/GlobalPeter Drucker Forum, Vienna (since 2009)

Former activities and functions:

  • Member Advisory Board UBS Unique (2017-2018)
  • Director Trinnacle Fund Ltd. (2016–2017)
  • Member Board of Directors Teralytics AG (2013–2016)
  • Founder & CEO Ifitech GmbH, Germany (2010–2017)
  • International investor in biotech and tech, based in Germany(2000–2013)
  • International consultant for strategy, management, investments andrestructuring (1992–1999)
  • Head global restructuring Behringwerke AG, Germany (1990–1992)
  • Member Board Staff Hoechst AG, Germany (1988–1990)
  • International Marketing Group Leader at Behringwerke AG(1986–1988)
  • MD Anderson Cancer Center, Houston and Memorial Sloan KetteringCancer Center, New York, USA – various cancer research functions               
     
Christoph Maeder  

Christoph Mäder holds a Master’s degree in Law from the University of Basel and is admitted to the Swiss Bar.  

 

  • Member of the Board of Directors of Lonza Group Ltd (since April 2016)

 

Current activities and functions: 

  • Member of the Board Committee of economiesuisse (since 2017)
  • Member of the Board of scienceindustries (since 2003)
  • Member of the Board of the Basel Chamber of Commerce (since 2002)
  • Member of the Group Executive Committee of Syngenta (since 2000)         

Former activities and functions:

  • Vice Chairman of economiesuisse (2011–2017)
  • Member of the Executive Board of the Business and Industry Advisory Committee (BIAC) for the Organization for Economic Cooperation and Development (OECD) (2012–2016)
  • Head of Legal & Public Affairs for Novartis Crop Protection AG (1999–2000)
  • Senior Corporate Counsel for Novartis International AG (1992–1998)
     
Richmond Barbara

Barbara M. Richmond holds a first-class degree in Management Science from the University of Manchester Institute of Science and Technology in England. Barbara Richmond has substantial knowledge as financial expert, demonstrated by her roles as CFO for various companies. She is a Fellow of the Institute of Chartered Accountants in England and Wales.


  • Member of the Board of Directors of Lonza Group Ltd (since April 2014)

 

Current activities and functions: 

  • Group CFO of Redrow plc (since 2010)

Former activities and functions:

  • Group CFO of Inchcape plc, (2006–2009)
  • Non-Executive Director and Audit Committee Chair of Scarborough Building Society until its merger with The Skipton Building Society (2005–2009)
  • Non-Executive Director, Senior Independent Director and Audit Committee Chair of Carclo Group plc (2000 – 2006)
  • Group CFO of Croda International plc (1997–2006) with dual role as Group CFO and President of Active Ingredients and Industrial Chemicals from 2002 to 2006
  • Group CFO of Whessoe plc in1993 (1992–1997)
  • Various financial roles in Alstom Group SA (1987–1992)
  • Auditor and management consultant for Arthur Andersen (1981–1984)
     
Scheltema Margot
  

Margot Scheltema holds a doctorate in international law from the University of Amsterdam and a master of international affairs (MIA) from Columbia University in New York. Margot Scheltema has substantial knowledge as a finance, corporate governanceand risk management expert, demonstrated by her operative roles in finance and management and supervisory roles in the financial sector (bank, central bank, insurance and pension funds).

  • Member of the Board of Directors of Lonza Group Ltd (since April 2012)

 

Current activities and functions: 

  • Member of the Supervisory Board of the Dutch Central Bank (since 2015)
  • Member of the Central Plan Committee Dutch Planning Bureau (since 2014)
  • Chair of the Monitoring Committee of the Dutch Pension Fund Code (since 2014)
  • Council to the Enterprise Chamber of the Amsterdam Court of Appeal (since 2013)
  • Member of the Supervisory Board of Warmtebedrijf Rotterdam (since 2011)
  • Member of the Supervisory Board of TNT Express (since 2011)
  • Member of the Supervisory Board of Schiphol NV (since 2010)

Former activities and functions:

  • Vice Chair of the Supervisory Board of Triodos Bank (2006 –2015)
  • Member of the Supervisory Board of ASR NV (2008 –2015)
  • Member of the Supervisory Board of the Rijksmuseum (2007–2015)
  • External Member of the Audit Committee of the Dutch pension fund ABP (2010 to July 2014)
  • Member of the Supervisory Board of ECN (2009–2013) Member of the AFM External Reporting Committee (2006–2012)
  • Financial Director of Shell Nederland BV (2004–2008)
  • Various managerial positions within the Shell Group (1985–2004)
     
Steinemann Juergen
  

Juergen Steinemann holds a degree in Economics and Business Management from the European Business School in Wiesbaden, London and Paris.

 

  • Member of the Board of Directors of Lonza Group Ltd (since April 2014)

 

Current activities and functions: 

  • Investor in food and agri businesses
  • Managing Director of JBS Holding GmbH (since 2017)
  • Chairman of the Supervisory Board of Bankiva B.V. (since 2017)
  • Member of the Advisory Board of Tower Brook Capital Partners LP (since 2017)
  • Member of the Board of Directors of Barry Callebaut AG (since 2015)
  • Chairman of the Supervisory Board of Metro Group AG (since 2015)
  • Member of the Supervisory Board of Big Dutchman AG (since 2015)

Former activities and functions:

  • Chief Executive Officer of Barry Callebaut Ltd (2009–2015)
  • Member of the Board of the SwissAmerican Chamber of Commerce (2011–2015)
  • Member of the Executive Board and Chief Operating Officer of Nutreco (2001–2009)
  • Chief Executive Officer of Loders Croklaan (1999–2001)
  • Various senior positions in businesstobusiness marketing and sales with the former Eridania BéghinSay Group, ultimately in the “Corporate Plan et Stratégie” unit at the head office in Paris (1990–1998)
        
     
Trius Antonio
  

Antonio Trius holds a Bachelor's degree in Organic Chemistry from the University of Barcelona, a PhD in Chemistry from the Autonomous University of Barcelona and a PDD in Business Administration from the IESE Barcelona. Antonio Trius has substantial knowledge in the operational and financial management and supervision of companies in the chemical and pharmaceutical industry.

 

  • Member of the Board of Directors of Lonza Group Ltd (since April 2013)

 

Current activities and functions: 

  • Member of the Advisory Board of Naturally Scientific Technologies Ltd. (since 2017)
  • Member of the Board of Directors of Cuantum Medical & Cosmetics S.L. (since 2015)
  • Member of the Board of Directors of MaxamCorp Holding S.L. (since 2014)
  • Member of the Board of Directors of Azelis SA (since 2014)
  • Member of the Supervisory Board of Altana AG (since 2012)

Former activities and functions:

  • Member of the Board of Directors of Mauser Group BV (2015–2017)
  • Member of the Board of Directors of Nubiola SL (2011–2015)
  • CEO of Cognis GmbH (2001–2010)
  • Executive Vice President Care Chemicals North America Cognis BV (1999–2001)
  • Vice President Care Chemicals at Henkel KGa A (1997–1999) 
     

Olivier Verscheure

  

 Olivier Verscheure holds a Ph.D. degree in computer science from the Swiss Federal Institute of Technology, Lausanne (EPFL, July 1999)

 

  • Member of the Board of Directors of Lonza Group Ltd (since May 2018) 

 

Current activities and functions: 

  • Executive Director of the Swiss Data Science Center, a joint venture between EPFL and ETH Zurich (since May 2016)
  • Member of the Executive Committee of the Personalized Health and Related Technologies (PHRT), an ETH Domain Strategic Focus Area (since January 2017)
  • Co-academic Director, Certificate of Advanced Studies (CAS), Data Science and Management, HEC Lausanne and EPFL(since March 2018)

 

Former activities and functions:

  • Lab Program Director and Senior Research Manager at IBM Research Ireland (August 2010 – May 2016)
  • Research Manager and Senior Member of the Research Staff at the IBM T.J. Watson Research Center(July 1999 – August 2010)